Activity of 4′-0-tetrahydropyranyladriamycin hydrochloride (THP-ADM) in a human tumor cloning system Katsuhiro InoueMasayuki ArakawaMakoto Ogawa Preclinical Pages: 271 - 275
Usefulness of abrin as a positive control for the human tumor clonogenic assay Sydney E. SalmonRosa LiuRichard Roberts Preclinical Pages: 277 - 281
The cytokinetic and cytotoxic effects of ICRF-159 and ICRF-187 in vitro and ICRF-187 in human bone marrow in vivo Richard H. WheelerDaniel J. ClauwRaymond W. Ruddon Preclinical Pages: 283 - 295
Human muscle: a model for the study of human neoplasia John C. PetriccianiInessa LevenbookRobert Locke Preclinical Pages: 297 - 302
Spiromustine: a new agent entering clinical trials D. Dale ShoemakerPeter J. O'DwyerRuth D. Davis Clinical Pages: 303 - 308
Phase I trial with 4′-deoxydoxorubicin (esorubicin) Marcel RozencweigNadine CrespeigneYvon Kenis Clinical Pages: 309 - 313
Phase II evaluation of rubidazone (NSC-164011) in advanced carcinoma of the breast Frank E. SmithNazil Gad-el-MawlaMary Foulkes Clinical Pages: 315 - 319
High dose chemotherapy with autologous marrow rescue in the treatment of resistant solid tumors Charles F. LeMaistreWilliam A. Knight III Clinical Pages: 321 - 329
Pharmacokinetics of high dose melphalan Marla R. HershThomas M. LuddenWilliam A. Knight III Clinical Pages: 331 - 334
Colchicine in refractory chronic lymphocytic leukemia James K. WeickRobert B. LivingstonEllis J. Van Slyck Clinical Pages: 335 - 338
Prospective study of left ventricular function using radionuclide scans in patients receiving mitoxantrone Matti S. AaproDavid S. AlbertsCindy Mackel Clinical Pages: 341 - 347
Clinical evaluation of 4′-epi-doxorubicin in advanced solid tumors Gioacchino Robustelli Della CunaLorenzo PavesiFabrizio Ganzina Clinical Pages: 349 - 353
